Mago nashi homolog 2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-84153
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of Mago nashi homolog 2. Peptide sequence: LWPPPDRVGRQELEIVIGDEHISFTTSKIGSLIDVNQSKDPEGLRVFYYL The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for Mago nashi homolog 2 Antibody
![Western Blot: Mago nashi homolog 2 Antibody [NBP2-84153]](https://resources.bio-techne.com/images/products/Mago-nashi-homolog-2-Antibody-Western-Blot-NBP2-84153-img0001.jpg "Western Blot: Mago nashi homolog 2 Antibody [NBP2-84153]")
Western Blot: Mago nashi homolog 2 Antibody [NBP2-84153]
Western Blot: Mago nashi homolog 2 Antibody [NBP2-84153] - WB Suggested Anti-MAGOHB Antibody. Titration: 1.0 ug/ml. Positive Control: A549 Whole CellApplications for Mago nashi homolog 2 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Mago nashi homolog 2
Alternate Names
FLJ10292, mago, magoh, MAGOH2, mago-nashi homolog 2, mago-nashi homolog B (Drosophila), MGN2, protein mago nashi homolog 2
Gene Symbol
MAGOHB
Additional Mago nashi homolog 2 Products
Product Documents for Mago nashi homolog 2 Antibody
Product Specific Notices for Mago nashi homolog 2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...